ADRs End Slightly Higher; AstraZeneca, BT Group and Diageo Trade Actively
February 26 2019 - 5:59PM
Dow Jones News
International stocks trading in New York closed slightly higher
Tuesday.
The BNY Mellon index of American depositary receipts rose 0.2%
to 141.14. The European index increased 0.4% to 129.40. The Asian
index was nearly flat at 166.51. The Latin American index rose 0.3%
to 252.51. And the emerging-markets index remained flat at
313.42.
AstraZeneca PLC (AZN), BT Group PLC (BT) and Diageo PLC (DEO)
were among those with ADRs that traded actively.
AstraZeneca's Chief Executive Pascal Soriot told senators that
the company would be prepared to reduce its list prices by an
equivalent amount to the behind-the-scenes discounts that it offers
insurers and other middlemen, less the fees attached to them. That
move would be an extraordinary cut in prices; these discounts,
known as rebates, averaged around 50% of gross revenue, Dr. Soriot
said in his testimony. Still, that promise only would hold under a
sweeping overhaul of the drug-pricing system, according to the
AstraZeneca chief. ADRs of AstraZeneca rose 1.2% to $41.98.
BT Group shareholders risk a dividend cut when CEO Philip Jansen
unveils in May his strategy for the British telecommunications
company, Berenberg says. "We believe he will outline a
pro-investment, pro-growth vision and repair political and
regulatory relations at the start of his tenure. We do not think BT
has the cash flow to be able to do this without risk to the
dividend," analysts at the investment bank say. Prioritizing
investment over the dividend may be right for the company's
long-term interests, but its share price is too expensive to be
patient, the bank says. Berenberg cuts the stock to hold from buy.
ADRs of BT Group fell 1.7% to $14.79.
Diageo said Tuesday that it approached China's Sichuan
Shuijingfang Company Ltd. with a proposal to increase its stake in
the company to 70% from 60%. The stake increase would be achieved
through a partial tender offer at 45.00 Chinese yuan ($6.72) a
share, the FTSE 100 beverage company said. Diageo said the outlined
proposal doesn't constitute an offer and creates no obligation to
make an offer. The proposal is still under discussion and there is
no certainty any offer will be made, the owner of Johnnie Walker
whisky and Tanqueray gin brands said. ADRs of Diageo rose 0.4% to
$157.01.
(END) Dow Jones Newswires
February 26, 2019 17:44 ET (22:44 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
BT (NYSE:BT)
Historical Stock Chart
From Dec 2024 to Jan 2025
BT (NYSE:BT)
Historical Stock Chart
From Jan 2024 to Jan 2025